Coherus Oncology CHRS
NASDAQ CHRS
$0.75 +0.00 (+0.56%)
As of: Nov 6, 2026 · 9:54 AM EST

Coherus Oncology (CHRS) Shares Repurchased (2014)

Updated

Analysis

Coherus Oncology (CHRS) Shares Repurchased (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,221.54 Bn 1,195.15 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 650.21 Bn 570.07 Bn 17.30 Bn 1.71 Bn
3 AbbVie 508.24 Bn 476.24 Bn 13.12 Bn 5.00 Mn
4 Merck 360.07 Bn 323.01 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 312.26 Bn 285.49 Bn - -
6 Astrazeneca 285.31 Bn 259.20 Bn 13.26 Bn -
7 Amgen 247.74 Bn 199.39 Bn 7.58 Bn -
8 Gilead Sciences 207.12 Bn 182.22 Bn 6.73 Bn 370.00 Mn
9 Pfizer 166.13 Bn 113.48 Bn 12.56 Bn -
10 Coherus Oncology 116.17 Mn -519.97 Mn 10.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 2,000.00
API Access

Coherus Oncology Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=CHRS&period=max&api_key=YOUR_API_KEY